Temozolomide as First-Line Agent in Treating High-Grade Gliomas: Phase II Study

Author: Chibbaro S.   Benvenuti L.   Caprio A.   Carnesecchi S.   Pulerà F.   Faggionato F.   Serino D.   Galli C.   Andreuccetti M.   Buxton N.   Gagliardi R.  

Publisher: Springer Publishing Company

ISSN: 0167-594X

Source: Journal of Neuro-Oncology, Vol.67, Iss.1-2, 2004-03, pp. : 77-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content